FindTrial
Sign In

The impact of hemoperfusion on cognitive impairment in hemodialysis patients

The impact of hemoperfusion on cognitive impairment in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095969
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Interventions

HP group:None
HD group:None

Sponsors

Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1.Maintenance hemodialysis patients at Huashan Hospital from 2013 to 2024; 2.Maintenance hemodialysis for >=3 months, aged >=18 years;

Exclusion criteria

Exclusion criteria: 1.Patients with severe infections, tumors, severe cardiovascular diseases, severe hematologic disorders, or severe gastrointestinal diseases; 2.Patients receiving combined hemodialysis and peritoneal dialysis treatment; 3.Other conditions deemed unsuitable for inclusion in this study by the researchers.

Design outcomes

Primary

MeasureTime frame
Cognitive function;—

Countries

China

Contacts

Public ContactChen Jing,Qian Jing,Mengjing Wang,

Huashan Hospital Affiliated to Fudan University

fiyona27@126.com+86 137 6467 6029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026